Early complications of high-dose-rate brachytherapy in soft tissue sarcoma: A comparison with traditional external-beam radiotherapy

Cynthia L. Emory, Corey O. Montgomery, Benjamin K. Potter, Martin E. Keisch, Sheila A Conway

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Background: Radiotherapy and surgery are routinely utilized to treat extremity soft tissue sarcoma. Multiple radiation modalities have been described, each with advantages and disadvantages, without one modality demonstrating clear superiority over the others. Questions/purposes: We determined the overall initial complication rate in patients receiving surgery and radiotherapy, which specific complications were found when comparing different modalities, and whether combination therapy increased the overall rate of complications compared with surgery and single-modality radiotherapy. Patients and Methods: We retrospectively reviewed the records of 190 patients who received external-beam radiotherapy (141 patients), high-dose-rate brachytherapy (37 patients), or both (12 patients). We evaluated 100 men and 90 women (mean age, 57 years; range, 18-94 years) for tumor size and subtype, comorbidities, stage, grade, margin of resection, type of adjuvant treatment, and complications. Minimum followup was 3 months (mean, 40 months; range, 3-155 months). Results: The most frequent early complications in the high-dose-rate brachytherapy cohort were infection, cellulitis, and seroma and/or hematoma. In the external-beam radiotherapy cohort, chronic edema, fibrosis, and chronic radiation dermatitis were more frequently encountered. The total number of early complications and overall incidence of major complications requiring further surgery were similar among the three cohorts, but a larger number of patients in the high-dose-rate brachytherapy group required subsequent surgery for infection compared with the external-beam radiotherapy group. Conclusions: High-dose-rate brachytherapy decreases radiation exposure and allows shorter duration of treatment compared with traditional external-beam radiotherapy but has a higher perioperative wound complication rate. Level of Evidence: Level III, therapeutic study. See the Guidelines for Authors for a complete description of levels of evidence.

Original languageEnglish
Pages (from-to)751-758
Number of pages8
JournalClinical Orthopaedics and Related Research
Volume470
Issue number3
DOIs
StatePublished - Mar 1 2012

Fingerprint

Brachytherapy
Sarcoma
Radiotherapy
Radiodermatitis
Seroma
Cellulitis
Therapeutics
Infection
Hematoma
Comorbidity
Edema
Fibrosis
Extremities
Guidelines
Radiation
Incidence
Wounds and Injuries
Neoplasms

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine

Cite this

Early complications of high-dose-rate brachytherapy in soft tissue sarcoma : A comparison with traditional external-beam radiotherapy. / Emory, Cynthia L.; Montgomery, Corey O.; Potter, Benjamin K.; Keisch, Martin E.; Conway, Sheila A.

In: Clinical Orthopaedics and Related Research, Vol. 470, No. 3, 01.03.2012, p. 751-758.

Research output: Contribution to journalArticle

Emory, Cynthia L. ; Montgomery, Corey O. ; Potter, Benjamin K. ; Keisch, Martin E. ; Conway, Sheila A. / Early complications of high-dose-rate brachytherapy in soft tissue sarcoma : A comparison with traditional external-beam radiotherapy. In: Clinical Orthopaedics and Related Research. 2012 ; Vol. 470, No. 3. pp. 751-758.
@article{77a1db2e6d3f4eff9ac70f3aa549b954,
title = "Early complications of high-dose-rate brachytherapy in soft tissue sarcoma: A comparison with traditional external-beam radiotherapy",
abstract = "Background: Radiotherapy and surgery are routinely utilized to treat extremity soft tissue sarcoma. Multiple radiation modalities have been described, each with advantages and disadvantages, without one modality demonstrating clear superiority over the others. Questions/purposes: We determined the overall initial complication rate in patients receiving surgery and radiotherapy, which specific complications were found when comparing different modalities, and whether combination therapy increased the overall rate of complications compared with surgery and single-modality radiotherapy. Patients and Methods: We retrospectively reviewed the records of 190 patients who received external-beam radiotherapy (141 patients), high-dose-rate brachytherapy (37 patients), or both (12 patients). We evaluated 100 men and 90 women (mean age, 57 years; range, 18-94 years) for tumor size and subtype, comorbidities, stage, grade, margin of resection, type of adjuvant treatment, and complications. Minimum followup was 3 months (mean, 40 months; range, 3-155 months). Results: The most frequent early complications in the high-dose-rate brachytherapy cohort were infection, cellulitis, and seroma and/or hematoma. In the external-beam radiotherapy cohort, chronic edema, fibrosis, and chronic radiation dermatitis were more frequently encountered. The total number of early complications and overall incidence of major complications requiring further surgery were similar among the three cohorts, but a larger number of patients in the high-dose-rate brachytherapy group required subsequent surgery for infection compared with the external-beam radiotherapy group. Conclusions: High-dose-rate brachytherapy decreases radiation exposure and allows shorter duration of treatment compared with traditional external-beam radiotherapy but has a higher perioperative wound complication rate. Level of Evidence: Level III, therapeutic study. See the Guidelines for Authors for a complete description of levels of evidence.",
author = "Emory, {Cynthia L.} and Montgomery, {Corey O.} and Potter, {Benjamin K.} and Keisch, {Martin E.} and Conway, {Sheila A}",
year = "2012",
month = "3",
day = "1",
doi = "10.1007/s11999-011-2106-5",
language = "English",
volume = "470",
pages = "751--758",
journal = "Clinical Orthopaedics and Related Research",
issn = "0009-921X",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Early complications of high-dose-rate brachytherapy in soft tissue sarcoma

T2 - A comparison with traditional external-beam radiotherapy

AU - Emory, Cynthia L.

AU - Montgomery, Corey O.

AU - Potter, Benjamin K.

AU - Keisch, Martin E.

AU - Conway, Sheila A

PY - 2012/3/1

Y1 - 2012/3/1

N2 - Background: Radiotherapy and surgery are routinely utilized to treat extremity soft tissue sarcoma. Multiple radiation modalities have been described, each with advantages and disadvantages, without one modality demonstrating clear superiority over the others. Questions/purposes: We determined the overall initial complication rate in patients receiving surgery and radiotherapy, which specific complications were found when comparing different modalities, and whether combination therapy increased the overall rate of complications compared with surgery and single-modality radiotherapy. Patients and Methods: We retrospectively reviewed the records of 190 patients who received external-beam radiotherapy (141 patients), high-dose-rate brachytherapy (37 patients), or both (12 patients). We evaluated 100 men and 90 women (mean age, 57 years; range, 18-94 years) for tumor size and subtype, comorbidities, stage, grade, margin of resection, type of adjuvant treatment, and complications. Minimum followup was 3 months (mean, 40 months; range, 3-155 months). Results: The most frequent early complications in the high-dose-rate brachytherapy cohort were infection, cellulitis, and seroma and/or hematoma. In the external-beam radiotherapy cohort, chronic edema, fibrosis, and chronic radiation dermatitis were more frequently encountered. The total number of early complications and overall incidence of major complications requiring further surgery were similar among the three cohorts, but a larger number of patients in the high-dose-rate brachytherapy group required subsequent surgery for infection compared with the external-beam radiotherapy group. Conclusions: High-dose-rate brachytherapy decreases radiation exposure and allows shorter duration of treatment compared with traditional external-beam radiotherapy but has a higher perioperative wound complication rate. Level of Evidence: Level III, therapeutic study. See the Guidelines for Authors for a complete description of levels of evidence.

AB - Background: Radiotherapy and surgery are routinely utilized to treat extremity soft tissue sarcoma. Multiple radiation modalities have been described, each with advantages and disadvantages, without one modality demonstrating clear superiority over the others. Questions/purposes: We determined the overall initial complication rate in patients receiving surgery and radiotherapy, which specific complications were found when comparing different modalities, and whether combination therapy increased the overall rate of complications compared with surgery and single-modality radiotherapy. Patients and Methods: We retrospectively reviewed the records of 190 patients who received external-beam radiotherapy (141 patients), high-dose-rate brachytherapy (37 patients), or both (12 patients). We evaluated 100 men and 90 women (mean age, 57 years; range, 18-94 years) for tumor size and subtype, comorbidities, stage, grade, margin of resection, type of adjuvant treatment, and complications. Minimum followup was 3 months (mean, 40 months; range, 3-155 months). Results: The most frequent early complications in the high-dose-rate brachytherapy cohort were infection, cellulitis, and seroma and/or hematoma. In the external-beam radiotherapy cohort, chronic edema, fibrosis, and chronic radiation dermatitis were more frequently encountered. The total number of early complications and overall incidence of major complications requiring further surgery were similar among the three cohorts, but a larger number of patients in the high-dose-rate brachytherapy group required subsequent surgery for infection compared with the external-beam radiotherapy group. Conclusions: High-dose-rate brachytherapy decreases radiation exposure and allows shorter duration of treatment compared with traditional external-beam radiotherapy but has a higher perioperative wound complication rate. Level of Evidence: Level III, therapeutic study. See the Guidelines for Authors for a complete description of levels of evidence.

UR - http://www.scopus.com/inward/record.url?scp=84856968899&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856968899&partnerID=8YFLogxK

U2 - 10.1007/s11999-011-2106-5

DO - 10.1007/s11999-011-2106-5

M3 - Article

C2 - 21960155

AN - SCOPUS:84856968899

VL - 470

SP - 751

EP - 758

JO - Clinical Orthopaedics and Related Research

JF - Clinical Orthopaedics and Related Research

SN - 0009-921X

IS - 3

ER -